by Administrator | Jul 19, 2017 | 340B, blog
As 340B stakeholders gathered to celebrate 25 years of the 340B program at this year’s 340B Coalition Summer Conference, attendees were provided with a wealth of knowledge. My time at the conference was largely focused on gathering information related to 340B...
by Administrator | Jul 3, 2017 | 340B, blog, HIV Treatment
June 27 was National HIV Testing Day, but HIV testing takes place year round. According to the Centers for Disease Control and Prevention (CDC), people are encouraged to learn about their HIV status, with the recommendation that men and woman between the ages of 13...
by Administrator | Feb 16, 2017 | 340B, blog
Audits are one more opportunity to demonstrate the program is working well We can only assume that audits were the focus of so much discussion at this year’s 340B Coalition Winter Conference because the changes that come with the installation of new government...
by Administrator | Aug 16, 2016 | 340B, blog
Curant Health is so much more than a specialty pharmacy. We treat our patients like family and are personally invested in nurturing long-term patient-care team relationships. So what makes us different? Start with the high touch, patient-centric support we offer to...
by Administrator | Jul 20, 2016 | 340B, blog, Hep C Cure
The FDA has programs in place to focus on the development and designations for new specialty drugs. The problem is that high prices are being paid for drugs that don’t come with a graded, tested and proven high outcomes guarantee. The Institute for Clinical and...
by Administrator | Jul 5, 2016 | 340B, blog, Hep C Cure
When discussing high cost drugs proven to cure a specific illness, such as hepatitis C treatment, it’s important to keep the following in mind: All stakeholders – manufacturers, pharmacy benefit managers, pharmacies, payers and business owners – want a say...
Recent Comments